Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 1997

View Archived Issues

New indication for liquid Nutropin approved by FDA

Digital Gene Technologies and Recordati collaborate on atherosclerosis research

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

Novel antifungal discovered by Takara Shuzo

Anticarcinogenic 2-thioflavones from Taiho

SS Pharm. discloses platinum complexes

Mitsubishi Chemical isolates antihypertensive compound from natural source

Thymosin alpha 1 for DiGeorge syndrome

Novo Nordisk discloses metabotropic glutamate receptor antagonists

Schering-Plough claims adenosine A2a antagonists

Budesonide cleared in Canada for Crohn's disease

Shire's sustained-release carbamazepine deemed approvable by FDA

Gene therapy for radiation-induced salivary gland defects

Novel drug delivery system from Brown University shows promise

Annual Report: Emisphere Technologies

Company Profile: SangStat

Enzymes for anticancer drug design discovered and characterized

Company Profile: Oncogene Science

PPL Therapeutics produces salmon calcitonin in transgenic rabbits

Cortecs reports results with potential new class of anticancer compounds

GEM-91 associated with up to 90% decrease in cellular viremia in HIV-positive patients

Cardiosol associated with improved survival and reduced rejection in heart transplantation

Targeted Genetics' AAV vector useful for in vivo cardiovascular gene therapy

Antiangiogenic antibody from Ixsys enters clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...